U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H35N5.2Cl.Mn
Molecular Weight 483.38
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AVASOPASEM MANGANESE

SMILES

[Cl-].[Cl-].[Mn++].C1CC[C@@H]2NCC3=CC=CC(CN[C@H]4CCCC[C@@H]4NCCN[C@H]2C1)=N3

InChI

InChIKey=WXEMWBBXVXHEPU-NDOCQCNASA-L
InChI=1S/C21H35N5.2ClH.Mn/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20;;;/h5-7,18-25H,1-4,8-15H2;2*1H;/q;;;+2/p-2/t18-,19-,20-,21-;;;/m0.../s1

HIDE SMILES / InChI

Molecular Formula Mn
Molecular Weight 54.938
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C21H35N5
Molecular Weight 357.5361
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

M40419 (now GC4419) is a Mn(II)-containing pentaazamacrocyclic selective superoxide dismutase mimetic. It is a first-in-class, small molecule enzyme mimetic that converts superoxide to hydrogen peroxide and molecular oxygen. GC4419 is currently being evaluated in an ongoing randomized Phase 2 clinical trial to assess its effect on the incidence, severity and duration of severe oral mucositis (OM) when given to patients with squamous cell cancers of the head and neck in combination with radiation and chemotherapy. GC4419 has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration.

Approval Year

PubMed

PubMed

TitleDatePubMed
Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade.
2003 Jul
Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy.
2017 Sep 15
Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma.
2018 Feb 1
Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H₂O₂-Dependent Manner.
2018 Jan 19
Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease.
2019 Jan

Sample Use Guides

Treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:04:52 UTC 2023
Edited
by admin
on Fri Dec 15 16:04:52 UTC 2023
Record UNII
EY1WA413UL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AVASOPASEM MANGANESE
INN   USAN  
Official Name English
GC4419
Code English
avasopasem manganese [INN]
Common Name English
GC-4419
Code English
MANGANESE, DICHLORO((4AS,13AS,17AS,21AS)-1,2,3,4,4A,5,6,12,13,13A,14,15,16,17,17A,18,19,20,21,21A-EICOSAHYDRO-7,11-NITRILO-7H-DIBENZO(B,H)-5,13,18,21-TETRAAZACYCLOHEPTADECINE-.KAPPA.N5,.KAPPA.N13,.KAPPA.N18,.KAPPA.N21,.KAPPA.N22)-, (PB-7-11-2344'3')-
Systematic Name English
AVASOPASEM MANGANESE [USAN]
Common Name English
SC-72325A
Code English
M-40419
Code English
Avasopasem manganese [WHO-DD]
Common Name English
AVASOPASEM MANGANESE DICHLORIDE
Common Name English
(PBPY-7-11-2344'3')-DICHLORO((4AS,13AS,17AS,21AS)-1,2,3,4,4A,5,6,12,13,13A,14,15,16,17,17A,18,19,20,21,21A-ICOSAHYDRO-7,11-AZENO-7H-DIBENZO(B,H)(1,4,7,10)TETRAAZACYCLOHEPTADECINE-.KAPPA.5N5,N13,N18,N21,N22)MANGANESE
Systematic Name English
Code System Code Type Description
SMS_ID
100000177407
Created by admin on Fri Dec 15 16:04:52 UTC 2023 , Edited by admin on Fri Dec 15 16:04:52 UTC 2023
PRIMARY
PUBCHEM
23649345
Created by admin on Fri Dec 15 16:04:52 UTC 2023 , Edited by admin on Fri Dec 15 16:04:52 UTC 2023
PRIMARY
NCI_THESAURUS
C169797
Created by admin on Fri Dec 15 16:04:52 UTC 2023 , Edited by admin on Fri Dec 15 16:04:52 UTC 2023
PRIMARY
USAN
EF-74
Created by admin on Fri Dec 15 16:04:52 UTC 2023 , Edited by admin on Fri Dec 15 16:04:52 UTC 2023
PRIMARY
CAS
435327-40-5
Created by admin on Fri Dec 15 16:04:52 UTC 2023 , Edited by admin on Fri Dec 15 16:04:52 UTC 2023
PRIMARY
FDA UNII
EY1WA413UL
Created by admin on Fri Dec 15 16:04:52 UTC 2023 , Edited by admin on Fri Dec 15 16:04:52 UTC 2023
PRIMARY
INN
10802
Created by admin on Fri Dec 15 16:04:52 UTC 2023 , Edited by admin on Fri Dec 15 16:04:52 UTC 2023
PRIMARY
EVMPD
SUB192780
Created by admin on Fri Dec 15 16:04:52 UTC 2023 , Edited by admin on Fri Dec 15 16:04:52 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY